X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TALS

Closed

Talaris Therapeutics Inc

2.75
+0.03 (+1.10%)
Last Update: 20 Oct 2023 02:52:00
Yesterday: 2.72
Day's Range: 0. - 0.
Send
When Written:
 
1.83
Talaris Therapeutics Inc. is a biotechnology company that develops transformative cell therapies to treat and prevent life-threatening diseases. The company's lead product, FCR001, is a cell therapy designed to induce durable immune tolerance in patients receiving a kidney transplant. Talaris is also developing other cell therapies for the treatment of autoimmune diseases and other conditions. The company was founded in 2018 and is headquartered in Boston, Massachusetts. Talaris Therapeutics Inc. is backed by leading investors, including Blackstone Life Sciences and Longitude Capital.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X